BVT Aktienanleihe MRK 31.12.2024/ DE000VM7BUA9 /
22/05/2024 20:02:08 | Chg.+0.200 | Bid20:10:07 | Ask20:10:15 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
102.390EUR | +0.20% | 102.390 Bid Size: 50,000 |
102.990 Ask Size: 50,000 |
MERCK KGAA O.N. | 155.00 EUR | 31/12/2024 | Call |
GlobeNewswire
13:00
Medicenna to Present Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming Sachs 10th Annual...
GlobeNewswire
07/05
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
06/05
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
04/03
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
21/12/2023
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
14/12/2023
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
17/10/2023
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA